The abstract is read at the publisher; the summary is JClub's.
Pathogenic Gd-IgA1 is proposed as a disease-relevant subset of circulating galactose-deficient IgA1 in IgA nephropathy, potentially linked to hematuria and/or proteinuria.
- Why it matters: IgA nephropathy is heterogeneous, yet glomerular deposition of Gd-IgA1 is a shared pathological feature; recent trial data suggest not all circulating Gd-IgA1 may be equally pathogenic.
- What they did: The review re-evaluates evidence from longitudinal changes in serum Gd-IgA1 and proteinuria in therapeutic trials, then frames “pathogenic Gd-IgA1” around mucosal origin, selective mesangial deposition, and immune-complex/complement activation potential.
- The result: The concept may refine understanding of IgA nephropathy pathogenesis, support better use of emerging Gd-IgA1–targeting therapies, and guide development of treatments that selectively target this subset.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.